$24.17B in CY2024 Part D spend18.7M claims · 4.3M beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Semaglutide used for?
Semaglutide lowers blood sugar and promotes weight loss by mimicking the GLP-1 hormone, used in type 2 diabetes.
Is there a generic for Semaglutide?
No. Semaglutide is brand-only with no generic equivalents currently in market.
How much does my plan pay for Semaglutide?
Across 329 Part D plans, Semaglutide averages $273.32/unit (NADAC). Lowest available: $33.16/unit. Highest in distribution: $653.65/unit.
Is Semaglutide on the FDA shortage list?
No. Semaglutide is not currently on the FDA Drug Shortage Database.
9 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (15 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.